This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/drugbank/drug/DB06945/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB06945/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB06945/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB06945/identifier/drugbank/
n5http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB06945/identifier/chemspider/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06945
rdf:type
n3:Drug
n3:description
N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide is a solid. This compound belongs to the diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. This substance is known to target a disintegrin and metalloproteinase with thrombospondin motifs 5.
n3:group
experimental
owl:sameAs
n5:DB06945 n7:DB06945
dcterms:title
N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide
adms:identifier
n10:99443416 n11:294 n12:9933197 n13:8108825 n14:DB06945
n3:IUPAC-Name
n6:271B615C-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B6162-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B6161-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B615E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B615F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B6160-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B615A-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B6158-363D-11E5-9242-09173F13E4C5 n6:271B615B-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B6159-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n6:271B6168-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B6169-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B6163-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B6164-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B6166-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B6165-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B6167-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n6:271B616E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B6170-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B6171-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B616D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B616C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B616F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B615D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n6:271B616A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B616B-363D-11E5-9242-09173F13E4C5